Impact of gout on cardiovascular disease mortality: a meta-analysis

Jielin Yuan,Zhitao Xie,Bo Pan,Jingchang Zhang
DOI: https://doi.org/10.1007/s00393-024-01479-x
2024-02-03
Zeitschrift für Rheumatologie
Abstract:Background Several epidemiological studies have suggested that gout patients have a higher risk of cardiovascular disease mortality than healthy people. In contrast, the association between gout and cardiovascular disease (CVD) mortality was not obvious in other studies. In the present study, we aimed to investigate the relative risk for CVD mortality in gout patients in comparison to healthy controls. Methods Literature published before March 2023 was searched in Google Scholar, PubMed, and the Web of Science. We summarized the impact of gout on CVD mortality with a meta-analysis. Hazard ratios (HRs) and 95% confidence intervals (CIs) regarding the impact of gout on CVD mortality were summarized with STATA 12.0 software. Results Compared to individuals without gout, those with gout had higher mortality risks for CVD during follow-up, with a random effects model showing a risk of 1.30 (95% CI 1.15 to 1.48, p < 0.001; p -value for Cochran Q test < 0.001, I 2 = 95.9%). Similarly, subjects with gout had a mortality risk of 1.28 (95% CI 1.12 to 1.46, p < 0.001; p -value for Cochran Q test = 0.050, I 2 = 50.2%) for coronary heart disease (CHD) mortality during follow-up using the same statistical model. Furthermore, using a fixed effects model, individuals with gout had a mortality risk of 1.13 (95% CI 1.00 to 1.27, p = 0.049; p -value for Cochran Q test = 0.494, I 2 = 0.0%) for myocardial infarction (MI) mortality during follow-up. Conclusion In conclusion, this meta-analysis provides evidence supporting a markedly increased mortality risk from CVD and CHD as well as MI in patients with gout relative to reference subjects without gout.
rheumatology
What problem does this paper attempt to address?